These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29941177)

  • 1. Editorial overview: Cardiovascular and renal: Novel therapies in peripheral artery disease.
    Oikonomou E; Tousoulis D
    Curr Opin Pharmacol; 2018 Apr; 39():iv-vi. PubMed ID: 29941177
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive medical management of peripheral arterial disease.
    Gandhi S; Weinberg I; Margey R; Jaff MR
    Prog Cardiovasc Dis; 2011; 54(1):2-13. PubMed ID: 21722781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-Invasive Therapy of Peripheral Arterial Disease.
    Marcial JM; Pérez R; Vargas P; Franqui-Rivera H
    Bol Asoc Med P R; 2015; 107(3):52-7. PubMed ID: 26742197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical and lifestyle management of peripheral arterial disease.
    Parvar SL; Fitridge R; Dawson J; Nicholls SJ
    J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
    Rehring TF; Stolcpart RS; Hollis HW;
    J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes mellitus and coronary artery disease. Update on diagnosis and drug therapy].
    Marx N; Blessing E
    Dtsch Med Wochenschr; 2007 May; 132(19):1034-8. PubMed ID: 17476633
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current progress in the treatment for diabetic retinopathy in internal medicine].
    Hamada Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():173-7. PubMed ID: 12430225
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.
    Beckman JA; Paneni F; Cosentino F; Creager MA
    Eur Heart J; 2013 Aug; 34(31):2444-52. PubMed ID: 23625211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smile: saluto-metabolic interventions for life enhancement.
    Kalra S; Gupta N
    J Pak Med Assoc; 2019 Mar; 69(3):440-441. PubMed ID: 30890844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multifactorial Approach in Type 2 Diabetes Over 3 Years Decelerates Progression of Subclinical Arterial Disease in Routine Clinical Practice.
    Konstantonis G; Arida A; Aissopou E; Protogerou A; Tentolouris N; Sfikakis PP; Makrilakis K
    Angiology; 2021 Nov; 72(10):923-933. PubMed ID: 33906474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary medical prevention after primary vascular surgery between 1996 and 2006: a shift towards more evidence-based treatment.
    Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
    Eur J Prev Cardiol; 2013 Oct; 20(5):763-70. PubMed ID: 22637739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current therapeutics 2000].
    Scheen AJ
    Rev Med Liege; 2000 Sep; 55(9):852-61. PubMed ID: 11105601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe.
    Morrell J; Zeymer U; Baumgartner I; Limbourg T; Röther J; Bhatt DL; Steg PG;
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):270-7. PubMed ID: 20606595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus on: Screening and therapy of coronary heart disease in diabetic patients.
    Rivellese AA; Piatti PM;
    Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):757-64. PubMed ID: 21903366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.
    Sepúlveda C; Palomo I; Fuentes E
    Vascul Pharmacol; 2017 Apr; 91():10-17. PubMed ID: 28342822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical risk factor treatment in peripheral arterial disease. Need for further improvement.
    Alhadad A; Wictorsson C; Alhadad H; Lindblad B; Gottsäter A
    Int Angiol; 2013 Jun; 32(3):332-8. PubMed ID: 23711686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
    Alhadad A; Wiktorsson C; Lindblad B; Gottsäter A
    Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2322-5. PubMed ID: 20973248
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR
    J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hypertensive treatment in peripheral artery disease.
    Tsioufis C; Andrikou I; Siasos G; Filis K; Tousoulis D
    Curr Opin Pharmacol; 2018 Apr; 39():35-42. PubMed ID: 29459079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.